Upregulation of CXCR7 expression significantly restored the functions of EOCs from CAD patients, augmented expression of VEGFA and ultimately leaded to improved EOC-mediated in vitro vasculogenesis. The gene discussed is ACKR3; the disease is coronary artery disorder.